Share ownership Sinopharm Group Co. Ltd.

1099

CNE100000FN7

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 01:38:20 19/05/2026 pm IST			5-day change	1st Jan Change
17.68 ^HKD	+0.97%		-4.07%	-9.05%

27/04	Earnings Season, Tehran Proposal Lift Asian Stock Markets	MT
27/04	Sinopharm Group Records Drop in Q1 2026 Profit	MT

Share class: Sinopharm Group Co. Ltd.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,77,88,45,451	0	0	43 %
Stock B	1	1,34,18,10,740	1,34,18,10,740 ( 100 %)	0

Major shareholders: Sinopharm Group Co. Ltd.

Name	Equities	%	Valuation
Lazard Asset Management LLC 13.13 %	17,61,79,206	13.13 %	415 M $
Fidelity Management & Research Co. LLC 4.609 %	6,18,45,203	4.609 %	146 M $
BlackRock Fund Advisors 4.143 %	5,55,93,349	4.143 %	131 M $
FIAM LLC 2.898 %	3,88,89,214	2.898 %	92 M $
BlackRock Advisors (UK) Ltd. 1.644 %	2,20,57,488	1.644 %	52 M $
JPMorgan Asset Management (China) Co Ltd. 1.009 %	1,35,32,400	1.009 %	32 M $
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt) 0.896 %	1,20,23,200	0.896 %	28 M $
Fidelity Investments Canada ULC 0.803 %	1,07,74,800	0.803 %	25 M $
BlackRock Financial Management, Inc. 0.7744 %	1,03,90,400	0.7744 %	24 M $
BlackRock Investment Management (UK) Ltd. 0.549 %	73,66,810	0.549 %	17 M $
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
RhumbLine Advisers LP 0.00017 %	456	0.00017 %	5 376 $
PNC Wealth Management LLC 0.000165 %	444	0.000165 %	5 234 $
GAMMA Investing LLC 0.000068 %	182	0.000068 %	2 146 $
IMA Advisory Services, Inc. 0.00001 %	28	0.00001 %	330 $

Name	Equities	%	Valuation
China State-Owned Assets Supervision & Admn Commission 100 %	1,77,88,45,451	100 %	4 194 M $

Breakdown by shareholder type

Governments	132.58%
Institutional	35.43%
Individuals	0.01%

Based on 1000 largest holdings

Geographical origin of shareholders

China	136.01%
United States	26.49%
United Kingdom	2.88%
Canada	0.84%
Hong Kong	0.66%
Denmark	0.28%
Germany	0.19%
Sweden	0.14%
Japan	0.11%
Switzerland	0.08%
Netherlands	0.07%
Ireland	0.06%
Luxembourg	0.05%
Australia	0.05%
Italy	0.05%
Singapore	0.02%
France	0.02%
Individuals	0.01%
India	0.01%
Austria	0.01%
South Africa	0.01%

Based on 1000 largest holdings

Sinopharm Group Co Ltd is a China-based company principally engaged in the wholesale and retail of pharmaceutical and healthcare products and medical devices. The Company operates its business through four segments. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services to domestic and foreign pharmaceutical and health product manufacturers and other suppliers. The Device Distribution segment distributes medical devices to customers. The Pharmaceutical Retail Business segment owns a network of retail pharmacies that are directly operated or franchised. The Other Business segment is engaged in the manufacture and sale of pharmaceuticals, chemical reagents and laboratory supplies.

Employees

94,910

Sector

Pharmaceuticals

Calendar

23/06 - Ex-dividend date - 0.69 HKD

More about the company